CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering [Yahoo! Finance]
CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]